Universe Pharmaceuticals Stock Net Asset
| UPC Stock | USD 1.79 0.06 3.24% |
Universe Pharmaceuticals fundamentals help investors to digest information that contributes to Universe Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Universe Stock. The fundamental analysis module provides a way to measure Universe Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Universe Pharmaceuticals stock.
Universe |
Universe Pharmaceuticals Company Net Asset Analysis
Universe Pharmaceuticals' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Universe Pharmaceuticals Net Asset | 53.29 M |
Most of Universe Pharmaceuticals' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Universe Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Universe Pharmaceuticals has a Net Asset of 53.29 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Universe Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Universe Pharmaceuticals' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Universe Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Universe Pharmaceuticals by comparing valuation metrics of similar companies.Universe Pharmaceuticals is currently under evaluation in net asset category among its peers.
Universe Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0565 | ||||
| Profit Margin | (0.69) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | (1.96 M) | ||||
| Shares Outstanding | 1.58 M | ||||
| Shares Owned By Insiders | 8.79 % | ||||
| Shares Owned By Institutions | 2.80 % | ||||
| Number Of Shares Shorted | 281.85 K | ||||
| Price To Earning | 3.02 X | ||||
| Price To Book | 0.11 X | ||||
| Price To Sales | 0.11 X | ||||
| Revenue | 32.31 M | ||||
| Gross Profit | 21.89 M | ||||
| EBITDA | (3.22 M) | ||||
| Net Income | (6.16 M) | ||||
| Cash And Equivalents | 28.58 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 5.48 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.06 X | ||||
| Book Value Per Share | 7.33 X | ||||
| Cash Flow From Operations | 1.12 M | ||||
| Short Ratio | 0.08 X | ||||
| Earnings Per Share | (76.35) X | ||||
| Number Of Employees | 225 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 2.92 M | ||||
| Total Asset | 53.29 M | ||||
| Retained Earnings | 10.16 M | ||||
| Working Capital | 23.06 M | ||||
| Net Asset | 53.29 M |
About Universe Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Universe Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Universe Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Universe Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out Universe Pharmaceuticals Piotroski F Score and Universe Pharmaceuticals Altman Z Score analysis. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.